Use your antibodies-online credentials, if available.
No Products on your Comparison List.
Your basket is empty.
Find out more
Show all species
Show all synonyms
Select your species and application
anti-Mouse (Murine) Antibodies:
anti-Rat (Rattus) Antibodies:
Go to our pre-filtered search.
Human Monoclonal TGFb Primary Antibody for - ABIN577154
Nishiyama, McDonough, Bruns, Burgeson: Type XII and XIV collagens mediate interactions between banded collagen fibers in vitro and may modulate extracellular matrix deformability. in The Journal of biological chemistry 1994
Show all 4 Pubmed References
Human Polyclonal TGFb Primary Antibody for IHC (p), ELISA - ABIN2476753
Goldraich, Ramos, Goldraich: Urography versus DMSA scan in children with vesicoureteric reflux. in Pediatric nephrology (Berlin, Germany) 1990
Show all 4 Pubmed References
Cow (Bovine) Monoclonal TGFb Primary Antibody for ELISA, FACS - ABIN2476751
Mahan, Ballal, Nanda: Mitral valve tear complicating percutaneous valvuloplasty: diagnosis by transesophageal Doppler color flow mapping. in American heart journal 1991
Show all 3 Pubmed References
The present study demonstrated that in human osteoarthritis fibroblastlike synoviocytes, TGF-beta (show TGFB1 Antibodies) signals via p-Smad2 (show SMAD2 Antibodies) and p-Smad1 (show GARS Antibodies)/5/8. Furthermore, it was demonstrated that LTBP-1 (show LTBP1 Antibodies) may modulate the activity of TGF-beta (show TGFB1 Antibodies) in human osteoarthritis fibroblastlike synoviocytes.
These data indicate that human amniotic epithelial cells (hAECs) endow potential anticancer properties on epithelial ovarian cancer in vivo and in vitro which is partially mediated by hAECsecreted TGFbeta1 (show TGFB1 Antibodies)-induced cell cycle arrest. This study suggests a potential application of hAECbased therapy against epithelial ovarian cancer.
Results demonstrated that TGF-beta1 regulated FUT1 and Lewis y expression by activating the MAPK/c-Fos pathway.
analysis of how the molecular mechanisms involved in the dual response to TGF-beta (show TGFB1 Antibodies) in cancer, and how tumor cells evolve to evade the tumor-suppressive responses of this signaling pathway and then hijack the signal, converting it into an oncogenic factor [review]
The present study demonstrated that the expression of LKB1 (show STK11 Antibodies) and SIK1 (show SIK1 Antibodies) was downregulated, while TGF-beta (show TGFB1 Antibodies) and epithelialmesenchymal transition protein expression levels were upregulated in clinical ovarian tumor tissues and cells.
TGFB1 (show TGFB1 Antibodies) was shown to induce Epithelialtomesenchymal transition, thereby promoting the migration and invasion of HepG2 cells via JAK (show JAK3 Antibodies)/STAT3 (show STAT3 Antibodies)/Twist signaling.
Expression of TGF-beta (show TGFB1 Antibodies) was closely related to hypertrophy of the ligamentum flavum.
lasma levels of all TGF-beta (show TGFB1 Antibodies) isoforms were not altered in adolescent Chronic fatigue syndrome.
these results indicated that Bone marrow-derived mesenchymal stem cells -conditioned medium suppressed the epithelial-mesenchymal transition which might be associated with TGF-B1/Smad3 (show SMAD3 Antibodies). This study provides the theoretical basis for the research of the mechanisms responsible for pulmonary disease.
we show that NORAD upregulates transforming growth factor-beta (TGF-beta) signaling and regulates TGF-beta (show TGFB1 Antibodies)-induced epithelial-to-mesenchymal transition (EMT (show ITK Antibodies))-like phenotype
TGF-beta1 (show TGFB1 Antibodies) stimulated lubricin (show PRG4 Antibodies) secretion by superficial zone chondrocytes at all densities with twice-a-week TGF-beta (show TGFB1 Antibodies) treatment. It is noteworthy that the daily treatment of TGF-beta1 (show TGFB1 Antibodies) increased lubricin (show PRG4 Antibodies) much higher compared with twice-a-week treatment.
hypoxia increased the expression of platelet-derived growth factor (PDGF (show PDGFA Antibodies)) and transforming growth factor-beta1 (TGF-beta1 (show TGFB1 Antibodies)) and decreased the expression of neprilysin (NEP (show MME Antibodies)), which contributed to the hypoxia-induced Endothelial-to-mesenchymal transition of pulmonary artery endothelial cells.
TGF-beta1 (show TGFB1 Antibodies) modulates the expression of syndecan-4 (show SDC4 Antibodies) in cultured vascular endothelial cells in a biphasic manner.
Taken together, Staphylococcus aureus induces TGF-beta1 (show TGFB1 Antibodies) and bFGF (show FGF2 Antibodies) expression through the activation of AP-1 (show JUN Antibodies) and NF-kappaB (show NFKB1 Antibodies) in bovine mammary gland fibroblasts.
The results identify TGFB1 (show TGFB1 Antibodies) and ESRRA (show ESRRA Antibodies) as likely transcriptional regulators of rumen epithelial development and energy metabolism, respectively, and provide targets for modulation of rumen development and function in the growing calf.
the combined treatment with TGF-beta1 (show TGFB1 Antibodies) and BMP-7 (show BMP7 Antibodies) or treatment first with TGF-beta1 (show TGFB1 Antibodies) followed by BMP-7 (show BMP7 Antibodies) was more effective than other treatment groups in both chondrogenic differentiation and SZP (show PRG4 Antibodies) secretion.
Tenascin-X (show TNXB Antibodies) promotes activation of latent TGF-beta1 (show TGFB1 Antibodies) and subsequent epithelial to mesenchymal transition in mammary epithelial cells.
a detailed computational model for TGF-beta (show TGFB1 Antibodies) signalling that incorporates elements of previous models together with crosstalking between Smad1 (show SMAD1 Antibodies)/5/8 and Smad2 (show SMAD2 Antibodies)/3 channels through a negative feedback loop dependent on Smad7 (show SMAD7 Antibodies).
Endogenous TGF-beta1 (show TGFB1 Antibodies) became more bioactive following activation of the transgene protein product in chondrocytes.
A novel peptide, P2K, regulating TGF-beta1 (show TGFB1 Antibodies) signaling had an anabolic effect on bovine intervertebral disc cells and rabbit degenerated discs.
Data indicate that cardiac contractility modulation (CCM) therapy exerted protective effects against myocardial fibrosis potentially by inhibiting TGF-beta1 (show TGFB1 Antibodies)/Smad3 (show SMAD3 Antibodies) signaling pathway in chronic heart failure .
study suggested that TGF-beta1/Smad3/smad7 is a major pathway which plays an important role in the regulation of the IUA and specific inhibitor of Smad3 (SIS3) may provide a new therapeutic strategy for IUA.
cell therapy promoted TGF-beta1 (show TGFB1 Antibodies) expression in nucleus pulposus, leading to anti-inflammatory effects via the inhibition of NF-kappaB (show NFKB1 Antibodies), and the amelioration of disc degradation.
that prenatal tracheal occlusion increases TGF-beta (show TGFB1 Antibodies)/Rho kinase (show ROCK1 Antibodies) pathway, myofibroblast differentiation, and matrix deposition in neonatal rabbit and human congenital diaphragmatic hernia lungs
observation. Based on the above results, we conclude that TGF-beta1 (show TGFB1 Antibodies)-immobilized PLGA-gelatin scaffold seeded with ASCs considerably enhances the quality of the tissue-engineered cartilage, therefore, advancing the field of cartilage tissue engineering
Smad7 (show SMAD7 Antibodies) plays a crucial role in antagonizing epithelial-mesenchymal transition induced by TGFbeta (show TGFB1 Antibodies) signaling and is a Notch (show NOTCH1 Antibodies) signaling target in limbal epithelial stem cells.
the role of IL-10 in inhibited allograft rejection may be associated with CD4+CD25+ regulatory T cells and IL-10, and may be independent of TGF-b
After NOTCH1 (show NOTCH1 Antibodies) knockdown and TGFB1 (show TGFB1 Antibodies) stimulation, rabbit mesenchymal stem cells expressed higher levels of proteoglycan (show Vcan Antibodies) and collagen II.
TGF-beta1 (show TGFB1 Antibodies) gene transcription significantly correlates with the surgical vaginal and dermal wound closure rate.
TGF beta (show TGFB1 Antibodies) is involved in the pathogenesis of tympanosclerosis.
There was significantly higher expression of TGF-beta1 (show TGFB1 Antibodies) and MMP-9 (show MMP9 Antibodies) in nasal mucosa of experimental allergic rhinitis guinea pigs than in controls.
TGF-beta1 (show TGFB1 Antibodies) regulated pAKT (show AKT1 Antibodies) and IFNgamma expressions were associated with epithelial cell survival in rhesus macaque colon explants and suggest a potential role of mucosal TGF-beta1 (show TGFB1 Antibodies) in regulating intestinal homeostasis and EC integrity.
SIV infection of rhesus macaques results in the emergence of IL-17 (show IL17A Antibodies)-expressing cells during the acute phase. This subpopulation appears at day 14 postinfection concomitantly with an increase in TGF-beta (show TGFB1 Antibodies) and IL-18 (show IL18 Antibodies) expression.
SIV-infected macaques exhibiting progression to AIDS displayed greater expression of TGF-beta (show TGFB1 Antibodies) and indoleamine 2,3 dioxygenase in CD8 (show CD8A Antibodies)+ T cells from mesentric lymph nodes.
TGF-beta1 (show TGFB1 Antibodies) is activated or inactivated by MMP20 or KLK4 (show KLK4 Antibodies) and that the amelogenin (show AMELX Antibodies) cleavage product is necessary for the in-solution mobility of TGF-beta1 (show TGFB1 Antibodies).
Activated TGF-beta (show TGFB1 Antibodies) signaling rescued miR (show MYLIP Antibodies)-143-reduced FSHR (show FSHR Antibodies) and intracellular signaling molecules, and miR (show MYLIP Antibodies)-143-induced porcine granulosa cell apoptosis.
TGF-beta1 (show TGFB1 Antibodies)-induced epithelial-myofibroblast plasticity is FAK (show PTK2 Antibodies)- dependent, whereas TGF-beta1 (show TGFB1 Antibodies)-induced apoptosis is favored when FAK (show PTK2 Antibodies) signaling is inhibited.
this study shows that TGF-beta1 (show TGFB1 Antibodies) protects intestinal integrity and influences Smad (show SMAD1 Antibodies) and MAPK (show MAPK1 Antibodies) signal pathways in intestinal epithelium cells after TNF-alpha (show TNF Antibodies) challenge
this study shows that anemonin may ameliorate LPS (show IRF6 Antibodies)-induced intestinal injury and improve restoration by regulating the TGF-b1 and EGFR (show EGFR Antibodies) signaling pathways
The results indicated that TGF-beta-1 (show TGFB1 Antibodies) was associated with the restoration of intestinal morphology and barrier function following weaning stress.
Data (including data from in vitro and in vivo experiments) suggest that day 14 elongated conceptus secretes proteins that up-regulate TGFbeta1 (show TGFB1 Antibodies) mRNA and TGFbeta1 (show TGFB1 Antibodies) expression in endometrium; TGFbeta1 (show TGFB1 Antibodies) may be important during pregnancy maintenance.
The effects of semen, spermatozoa in extender, or extender alone on the expression of TGF-beta1 (show TGFB1 Antibodies), IL-10 (show IL10 Antibodies), and IL-6 (show IL6 Antibodies) in ovarian follicles are reported.
Dietary (1,3/1,6)-beta-D-glucan reduced the mRNA expression of transforming growth factor (TGF) beta2 (show TGFB2 Antibodies) and tended to reduce the mRNA expression of TGF-beta1 (show TGFB1 Antibodies) in lung tissue of neonatal piglet.
TGF-beta1 (show TGFB1 Antibodies), via TGF-beta1 (show TGFB1 Antibodies) receptor I and p38 MAPK (show MAPK14 Antibodies) signaling, reduces CFTR (show CFTR Antibodies) expression to impair CFTR (show CFTR Antibodies)-mediated anion secretion, which would likely compound the effects associated with mild CFTR (show CFTR Antibodies) mutations and ultimately would compromise male fertility.
In obese mice, periodontitis caused the downregulation of MMP2 (show MMP2 Antibodies), and upregulation of TIMP1 (show TIMP1 Antibodies) and TGF-beta1 (show TGFB1 Antibodies) at transcriptional and translational levels
The protective effect of the EP2 receptor on TGF-beta1 (show TGFB1 Antibodies) induced podocyte injury via the PI3K / Akt (show AKT1 Antibodies) signaling pathway.
This study demonstrates that prevention of renal apoB (show APOB Antibodies) accumulation is a mechanism by which TGF-beta (show TGFB1 Antibodies) inhibition is nephroprotective.
data show that increased TGFbeta (show TGFB1 Antibodies) in the tumour microenvironment represents a primary mechanism of immune evasion that promotes T-cell exclusion and blocks acquisition of the TH1 (show HAND1 Antibodies)-effector phenotype; immunotherapies directed against TGFbeta (show TGFB1 Antibodies) signalling may therefore have broad applications in treating patients with advanced colorectal cancer
IL 6 (show IL6 Antibodies) and TGF beta (show TGFB1 Antibodies) perform essential role in cerebral malaria pathogenesis by modulating the level of glial cell induced neuroinflammation.
The increased susceptibility to IMQ-induced psoriasis of GILZ (show TSC22D3 Antibodies)-Tg mice was significantly associated with skin-specific over-activation of TGF-beta1 (show TGFB1 Antibodies)-mediated signaling via SMAD2 (show SMAD2 Antibodies)/3.
The data suggest that B cells can down-regulate the function of antigen-presenting cells, and in turn encephalitogenic Th1 (show HAND1 Antibodies)/Th17 responses, via TGF-beta1 (show TGFB1 Antibodies).
p-SMAD2 (show SMAD2 Antibodies)/3 and p-ERK1/2 might play a regulatory role in TGF-beta1 (show TGFB1 Antibodies) induced CTGF (show CTGF Antibodies) exp p-SMAD2 (show SMAD2 Antibodies)/3 and p-ERK1/2 might play a regulatory role in TGF-beta1 (show TGFB1 Antibodies) induced CTGF (show CTGF Antibodies) expression during tooth development.
inhibiting NCAM1 (show NCAM1 Antibodies) would be cardioprotective, counteract the pathological action of TGFbeta1 (show TGFB1 Antibodies) and reduce heart failure severity.
TGF-beta (show TGFB1 Antibodies) signaling has a role in inhibiting tumor progression and invasion in an induced mouse bladder cancer model
This gene encodes a member of the transforming growth factor beta (TGFB) family of cytokines, which are multifunctional peptides that regulate proliferation, differentiation, adhesion, migration, and other functions in many cell types. Many cells have TGFB receptors, and the protein positively and negatively regulates many other growth factors. The secreted protein is cleaved into a latency-associated peptide (LAP) and a mature TGFB1 peptide, and is found in either a latent form composed of a TGFB1 homodimer, a LAP homodimer, and a latent TGFB1-binding protein, or in an active form composed of a TGFB1 homodimer. The mature peptide may also form heterodimers with other TGFB family members. This gene is frequently upregulated in tumor cells, and mutations in this gene result in Camurati-Engelmann disease.
TGF-beta 1 protein
, latency-associated peptide
, transforming growth factor beta-1
, transforming growth factor, beta 1 (Camurati-Engelmann disease)
, transforming growth factor-beta 1
, transforming growth factor beta 1
, transforming growth factor-beta
, transforming growth factor beta1
, transforming growth factor-beta-1
, TGF-beta 1
, regulatory protein
, transforming growth factor, beta-1